Aurora Sheboygan Prices: Cabazitaxel 60 Milligrams Per 1.5 Milliliters Intravenous Solution Costs $1,525.56

Cabazitaxel is an intravenous chemotherapy medication primarily used to treat prostate cancer that has progressed despite other therapies. At Aurora Medical Center Sheboygan County, the cost for a 60 milligram per 1.5 milliliter intravenous solution of Cabazitaxel is $1,525.56. This fee typically covers the drug itself and may also reflect aspects of the facility’s comprehensive cancer care services. However, additional costs for administration, monitoring, and supportive medications may apply. Patients are encouraged to request an itemized estimate in advance and verify their insurance coverage to better understand their out-of-pocket expenses.

Cost Breakdown

• Cabazitaxel (60 mg/1.5 mL IV solution): $1,525.56 (drug cost only)
• Potential additional charges:
  • IV administration fees
  • Pre-medication (e.g., anti-nausea drugs, steroids)
  • Monitoring (lab tests, vital sign checks)
  • Facility or infusion suite fees
  • Physician/oncologist consultation fees

Associated Costs to Consider

• Additional chemotherapy cycles or doses
• Supportive care (growth factors, antibiotics)
• Follow-up imaging or lab work
• Management of side effects or complications

Insurance & Payment Advice

• Contact your insurer to confirm if Cabazitaxel is covered and determine your co-pay or coinsurance responsibilities.
• Ask the medical center for a detailed, itemized estimate of all anticipated charges for your treatment plan.
• Inquire about financial assistance programs or payment plans if you anticipate difficulty covering costs.

Side Effect Considerations

• Common side effects: fatigue, nausea, decreased blood cell counts, diarrhea, and risk of infection.
• Discuss with your care team how side effects may be managed and whether additional medications or visits may be needed.

Recovery and Support Tips

• Arrange for transportation after treatment, as fatigue is common.
• Stay hydrated and maintain a balanced diet to support recovery.
• Monitor for signs of infection and report any concerns promptly.
• Schedule follow-up appointments as recommended by your oncology team.

Frequently Asked Questions

What is Cabazitaxel and what is it used for?

Cabazitaxel is a chemotherapy medication used mainly for prostate cancer that has become resistant to other forms of treatment.

How is Cabazitaxel administered?

It is given as an intravenous infusion, typically in a hospital or infusion center setting under close medical supervision.

Does the $1,525.56 fee include all costs related to treatment?

No, this fee typically covers only the cost of the Cabazitaxel medication. Additional charges for administration, monitoring, and supportive care may apply.

Will my insurance cover Cabazitaxel?

Coverage varies by insurance plan. Always confirm with your insurer whether Cabazitaxel and associated services are covered and what your personal responsibility will be.

Are there financial assistance options if I cannot afford the treatment?

Many hospitals and cancer centers offer financial assistance programs or payment plans. Ask the billing department about available options.

What are the common side effects of Cabazitaxel?

Common side effects include fatigue, nausea, diarrhea, decreased blood counts, and increased risk of infection. Always discuss side effect management with your medical team.

How should I prepare for my Cabazitaxel infusion?

Follow your care team’s instructions, which may include fasting, arranging transportation, and taking pre-medications to minimize side effects.

How long does a typical Cabazitaxel infusion take?

The infusion itself usually takes about an hour, but total time at the center may be longer due to preparation, monitoring, and post-infusion care.

Will I need multiple doses or cycles?

Cabazitaxel is often given in cycles, typically every three weeks. The number of cycles will depend on your individual treatment plan.

What should I do if I experience severe side effects?

Contact your healthcare provider immediately if you experience severe or unusual symptoms, such as high fever, uncontrolled vomiting, or signs of infection.

Aurora Medical Center Sheboygan County, located at 3400 Union Ave, Sheboygan, WI, offers a range of medical services, including specialized cancer treatments. One such treatment is Cabazitaxel, an intravenous chemotherapy medication used primarily for patients with prostate cancer that has progressed despite other treatments. At Aurora Sheboygan, the cost for Cabazitaxel is $1,525.56 for a 60 milligram per 1.5 milliliter intravenous solution. This pricing reflects the specialized nature of the drug and the comprehensive care provided by the facility.

What is Cabazitaxel used for? – Cabazitaxel is used as a chemotherapy treatment for prostate cancer, particularly in cases where the cancer has become resistant to other treatments.

How is Cabazitaxel administered? – Cabazitaxel is administered intravenously, meaning it is delivered directly into the bloodstream through an IV.

Why does Cabazitaxel cost $1,525.56 at Aurora Sheboygan? – The cost reflects the drug’s specialized nature, the complexity of cancer treatment, and the comprehensive care provided by the medical center.

Are there any side effects associated with Cabazitaxel? – Yes, common side effects include fatigue, nausea, and decreased blood cell counts, among others; patients should discuss potential side effects with their healthcare provider.

Is Cabazitaxel covered by insurance? – Coverage for Cabazitaxel varies by insurance plan; patients should check with their insurance provider to determine their specific coverage details.

How effective is Cabazitaxel in treating prostate cancer? – Cabazitaxel has been shown to be effective in extending survival and managing symptoms in patients with advanced prostate cancer, particularly when other treatments have failed.

Can anyone with prostate cancer use Cabazitaxel? – Cabazitaxel is typically prescribed for patients with advanced prostate cancer who have not responded to other treatments; eligibility should be determined by a healthcare professional.